Consumer

Customer service representatives interacting with a patient with a $500 balance who can only pay $50, should use that data to give that patient the option to set up 10 payments of $50, says Casey Williams, senior VP of patient engagement at RevSpring.

The company offers mental healthcare for children and their families and will use the funds to expand its reach.

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.

The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 

Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.

The Series E funding comes four months after the company secured $250 million in a Series D round.

The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.

Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.